2019-2023 Europe Infectious Disease Testing Market: A 31-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

This new report provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The report provides granular market segmentation analysis and forecasts for over 100 microbiology tests; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the worlds major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes, Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Country Analyses

Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK

Market Segmentation Analysis

- Sales and market shares of major suppliers of
infectious disease diagnostic products in major countries by test.

- Test and sales forecasts for 100 infectious disease diagnostic
assays by country, individual test and market segment:

- Review of market dynamics, trends,
structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of major diseases,
including their etiology, current diagnostic tests,
vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
testing, including their operating
characteristics, features and selling prices.

Technology Review

- Assessment of emerging diagnostic technologies and their potential
applications for infectious disease testing.

- Companies developing or
marketing infectious disease diagnostic products
by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.

Opportunities and Strategies for Suppliers

- Emerging opportunities for new instrumentation,
reagent systems, IT and other products with significant market
appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.


I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Overview of Major Tests,
Technologies and Instrumentation
A. Major Infectious Disease Tests
1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Carbapenemase
13. Chagas Disease
14. Chancroid
15. Chlamydia

16. Clostridium Difficile
17. Coronaviruses
18. Coxsackieviruses
19. Creutzfeldt-Jakobs Disease
20. Cryptosporidium Parvum
21. Cyclospora Cayetanensis
22. Cytomegalovirus
23. Ebola Virus
24. E. Coli
25. Echovirus
26. Encephalitis
27. Enteroviruses
28. Epstein-Barr Virus
30. Giardia Lamblia
31. Gonorrhea
32. Granuloma Inguinale
33. Hantavirus
34. Helicobacter Pylori
35. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
HBe Ag, ALT/SGPT
36. Herpes Simplex Virus
37. Human Herpes Virus-6 (HHV-6)
38. Influenza Viruses
39. Legionella
40. Lyme Disease
41. Lymphogranuloma Venereum (LGV)
42. Malaria
43. Measles (Rubeola)
44. Meningitis
45. Microsporidium
46. Mononucleosis
47. Mumps
48. Mycoplasma
49. Norovirus
50. Papillomaviruses
51. Parvovirus B19
52. Pneumonia
53. Polyomaviruses
54. Pseudomonas Aeruginosa
55. Rabies
56. Respiratory Syncytial Virus (RSV)
57. Rhinoviruses
58. Rotavirus
59. Rubella
60. Salmonellosis
61. Septicemia
62. Shigellosis

63. Staphylococcus Aureus
64. Streptococci
65. Syphilis
66. Toxoplasmosis
67. Trichomonas Vaginalis
68. Tuberculosis
69. Vibrio
70. West Nile Virus
71. Yersina
B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
VII. Country Analyses: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares
- Austria
- Belgium
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland

- Italy
- Latvia
- Lithuania
- Malta
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- UK
VIII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

List Of Tables

Austria
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Austria
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Belgium
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Belgium
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Bulgaria
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Bulgaria
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Croatia
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Croatia
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Cyprus
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Cyprus
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Czech Republic
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Czech Republic
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay

Denmark
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Denmark
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Estonia
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Estonia
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
Finland
All Market Segments Infectious Disease
Test Volume Forecast by Assay
Finland
All Market Segments Infectious Disease
Diagnostics Market Forecast by Assay
France Summary Table
All Infectious Diseases Test Volume and
Diagnostics Sales Forecast by Market Segment
France
Laboratories Performing Infectious Disease
Tests by Market Segment
France
Hospital Laboratories Performing Infectious
Disease Tests by Bed Size
France
Commercial/Private Laboratories Performing
Infectious Disease Tests by Annual Test Volume
France
All Market Segments Infectious Disease
Test Volume Forecast
France
All Market Segments Infectious Disease
Test Volume by Method

France
Hospital Laboratories Infectious Disease
Test Volume Forecast
France
Blood Banks Infectious Disease
Test Volume Forecast
France
Commercial/Private Laboratories Infectious
Disease Test Volume Forecast
France
All Market Segments Infectious
Disease Diagnostics Market Forecast
France
Hospital Laboratories Infectious Disease
Diagnostics Market Forecast
France
Blood Banks Infectious Disease
Diagnostics Market Forecast
France
Commercial/Private Laboratories Infectious Disease
Diagnostics Market Forecast
France
HIV/HIV-1/2/Combo, Test Volume
and Diagnostics Sales Forecast
by Market Segment
France
HIV Ag Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Western Blot/Other Confirmatory
Test Volume and Diagnostics Sales
Forecast by Market Segment
France
Adenovirus Test Volume and Diagnostics
Sales Forecast by Market Segment

France
Aeromonads Test Volume and Diagnostics
Sales Forecast by Market Segment
France
BEA Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Blastocystis Hominis Test Volume
and Diagnostics Sales Forecast
by Market Segment
France
Campylobacter Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Candida Test Volume and Diagnostics Sales
Forecast by Market Segment
France
Candida Test Volume and Diagnostics Sales
Forecast by Market Segment
France Carbapenemase
Chancroid Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Chlamydia Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Clostridium Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Coronavirus Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Coxsackievirus Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Cryptosporidium Test Volume and Diagnostics
Sales Forecast by Market Segment

France
CMV Test Volume and Diagnostics Sales
Forecast by Market Segment
France
Cyclospora Test Volume and Diagnostics
Sales Forecast by Market Segment
France
E. Coli Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Echovirus Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Encephalitis Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Enterovirus Test Volume and Diagnostics
Sales Forecast by Market Segment
France
EBV Test Volume and Diagnostics Sales
Forecast by Market Segment
France
Giardia Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Gonorrhea Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Granuloma Inguinale Test Volume
and Diagnostics Sales Forecast
by Market Segment
France
Hantavirus Test Volume and Diagnostics
Sales Forecast by Market Segment

France
Helicobacter Pylori Test Volume
and Diagnostics Sales Forecast
by Market Segment
France
HBsAg Test Volume and Diagnostics
Sales Forecast by Market Segment
France
HCV Test Volume and Diagnostics Sales
Forecast by Market Segment
France
HCV NAT Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Hepatitis C Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Anti-HBc Test Volume and Diagnostics Sales
Forecast by Market Segment
France
Anti-HBs Test Volume and Diagnostics Sales
Forecast by Market Segment
France
Anti-HAV Test Volume and Diagnostics Sales
Forecast by Market Segment
France
Hepatitis Delta Test Volume and Diagnostics
Sales Forecast by Market Segment
France
HAV NAT Test Volume and Diagnostics Sales
Forecast by Market Segment
France
HBV NAT Test Volume and Diagnostics Sales
Forecast by Market Segment
France
HBcAg Test Volume and Diagnostics Sales
Forecast by Market Segment

France
HBeAg Test Volume and Diagnostics
Sales Forecast by Market Segment
France
ALT/SGPT Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Herpes Simplex I and II Test Volume
and Diagnostics Sales Forecast
by Market Segment
France
Herpes Type VI Test Volume and
Diagnostics Sales Forecast
by Market Segment
France
HTLV I or HTLV I/HTLV II Test Volume
and Diagnostics Sales Forecast
by Market Segment
France
Influenza Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Legionella Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Lyme Disease Test Volume and Diagnostics

Global Blood Typing, Grouping and NAT Market, 2019-2023: Supplier Country Shares and Strategic Assessments of Key Players

This report presents extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. For each company the report provides:SalesMarket sharesProduct portfoliosMarketing tacticsTechnological know-howNew products in

USD 1850 View Report

Global Nucleic Acid Testing (NAT) Market, 2019-2023: Supplier Country Shares and Strategic Assessments of Key Players

This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing

USD 3500 View Report

Succeeding in the Europe Infectious Disease Testing Market, 2019-2023: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

The new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key trends in major

USD 17500 View Report

Europe Infectious Vaccines Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Europe Infectious Vaccines market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available